Polyvalent models for multifaceted diseases.

Cardiorenal syndrome (CRS) occurs when any acute or chronic dysfunction in either the heart or kidneys leads to a dysfunction in the other organ. In other words, it is a pathophysiological confluence of the cardiovascular and renal system, where for instance, kidneys fail to respond to a failing heart. The mortality rate of patients suffering from CRS depends on its subtype (types 1,2,3,4 and 5) as well as its comorbidities.

As mentioned earlier, cardiorenal syndrome has multiple subtypes. Being the result of a defective interplay between two failing organ systems, creating a preclinical model accurate enough posed a great challenge to all scientists alike. At PharmaLegacy, we rose to the challenge. Contact us now for more details.

Contact Us
Cardio-Renal Syndrome

Where pharmacology meets excellence:

  • FDA Part 11 compliant
  • 380,000 square feet of facility space
  • Operations and IT structured for maximum protection of clients’ data and IP
  • Capacity to run 200+ concurrent animal studies

At PharmaLegacy, we bridge basic research and clinical reality. Contact us now to turn your research into a clinical reality.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.